scispace - formally typeset
S

Stephen B. Liggett

Researcher at University of South Florida

Publications -  296
Citations -  24710

Stephen B. Liggett is an academic researcher from University of South Florida. The author has contributed to research in topics: Receptor & Agonist. The author has an hindex of 80, co-authored 285 publications receiving 23813 citations. Previous affiliations of Stephen B. Liggett include Washington University in St. Louis & University of Miami.

Papers
More filters
Journal ArticleDOI

Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.

TL;DR: The results indicate that the unique interactions of multiple SNPs within a haplotype ultimately can affect biologic and therapeutic phenotype and that individual SNPs may have poor predictive power as pharmacogenetic loci.
Journal ArticleDOI

Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

TL;DR: Three naturally occurring polymorphisms of the human beta 2-adrenergic receptor caused by missense mutations encoding for amino acids 16 and 27 of the extracellular N-terminus of the receptor are delineated and the functional consequences of these polymorphisms by site-directed mutagenesis and the recombinant expression of these receptors in Chinese hamster fibroblasts are studied.
Journal ArticleDOI

Transgenic Gαq overexpression induces cardiac contractile failure in mice

TL;DR: The Gαq overexpressor exhibits a biochemical and physiologic phenotype resembling both the compensated and decompensated phases of human cardiac hypertrophy and suggests a common mechanism for their pathogenesis.
Journal ArticleDOI

Mutations in the Gene Encoding for the β2-adrenergic Receptor in Normal and Asthmatic Subjects

TL;DR: The gene encoding the beta 2AR was examined to assess the frequency of polymorphisms in patients with moderate to severe asthma and normal subjects, and one mutation identified a subset of patients with a distinct clinical profile.